Galapagos NV

Galapagos NV GLPG

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of Galapagos NV shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for Galapagos NV
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Galapagos NV
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no Galapagos NV dividends.
Year Amount Change
2006 0.0¢
2007 0.0¢
remove
0%
2008 0.0¢
remove
0%
2009 0.0¢
remove
0%
2010 0.0¢
remove
0%
2011 0.0¢
remove
0%
2012 0.0¢
remove
0%
2013 0.0¢
remove
0%
2014 0.0¢
remove
0%
2015 0.0¢
remove
0%
2016 0.0¢
remove
0%
2017 0.0¢
remove
0%
2018 0.0¢
remove
0%
2019 0.0¢
remove
0%
2020 Sign Up Required

Galapagos NV Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 16 October 2020
52 Week Low
0.0% on 16 October 2020
Next Ex-Div-Date Countdown
Sign Up Required

About Galapagos NV

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biotechnology company, focused on the development and commercialization of novel medicines that will improve people's lives.

Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, Galapagos' most advanced novel mode-of-action program, was discovered using our proprietary target discovery technology, and is being developed by Gielad in Phase 3 in rheumatoid arthritis, Crohn's disease and ulcerative colitis. Galapagos is progressing multiple programs in inflammation, cystic fibrosis, metabolic diseases, fibrosis, and other disease areas.

Galapagos is listed on Euronext Amsterdam and Brussels and on the NASDAQ; all with the ticker symbol GLPG.

Sector
Pharmaceuticals & Biotechnology
Country
Netherlands
Share Price
€108.25 (yesterday's closing price)
Shares in Issue
46 million
Market Cap
€5.0bn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
AEX 25, BEL 20, STOXX600
Home Page URL
http://www.glpg.com/
Financial Calendar URL
Sign Up Required
No articles found